
PURIPHARM CO., LTD. · PuriActives® High-Performance Actives
OleaXin™ Oleanolic Acid Nanogel
齐肤因™ · Oleanolic Acid Nanogel
From a high-potential pentacyclic triterpene to a modern Nanogel active system.
INCI: Oleanolic Acid · Phospholipids · Glycerin · Water
Technical Marketing Presentation · For B2B Professional Use Only
01 · THE OPPORTUNITY
Why Refocus on Oleanolic Acid?
01 A Multi-Target Biological Foundation
Sebum regulation · inflammatory signaling · oxidative stress · ECM homeostasis · follicular microenvironment. Oleanolic acid is a pentacyclic triterpene widely found in olive, Ligustrum lucidum, and other plants, long followed by dermatological literature. Its value lies not in a single benefit, but in simultaneously touching multiple biological pathways related to oily skin, blemish-prone skin, and scalp health.
02 Skin + Scalp Dual Scenarios
Facial oil control and soothing share one mechanistic framework with scalp oil management.
03 A Deep Literature and Patent Base
From enzymology and cell studies to animal and human research, the evidence chain spans more than two decades.
04 Aligned with Oily-Skin and Scalp-Care Trends
Blemish-prone skin management, scalp microbiome care, and the “skinification” of hair care continue to gain momentum.
The scientific potential is high, yet formulation use is anything but simple — its highly lipophilic molecular nature has kept oleanolic acid a “research hotspot” rather than a “formulation regular.”
02 · MOLECULAR IDENTITY
Meet Oleanolic Acid: A Classic Pentacyclic Triterpene
Naming note: “石竹素” is the Chinese inventory name of Oleanolic Acid in China’s cosmetic ingredient system; the scientific narrative uses “齐墩果酸” (oleanolic acid), the name familiar to R&D professionals. Official ingredient information follows the INCI name.

| INCI name | Oleanolic Acid |
| Chinese inventory name | 石竹素 (Inventory of Existing Cosmetic Ingredients in China) |
| CAS number | 508-02-1 |
| Formula / MW | C₃₀H₄₈O₃ / 456.70 g·mol⁻¹ |
| Chemical class | Pentacyclic triterpene (β-amyrin type) |
| Natural sources | Olive leaves, Ligustrum lucidum, Centella asiatica, and other plants |
| Physicochemical profile | Highly lipophilic; practically insoluble in water |
A molecule studied for over half a century — as one of the active components of many medicinal plants, its anti-inflammatory, antioxidant, and metabolism-modulating activities have been repeatedly reported in pharmacological literature, and its skin and scalp biology value continues to be rediscovered.
References: Ayeleso TB et al. Molecules. 2017;22(11):1915. DOI:10.3390/molecules22111915; PubChem CID 10494.
03 · THE FORMULATION CHALLENGE
High Bioactivity Does Not Mean High Formulation Usability

Practical Impact for Formulators
Difficult to dose directly into water-based serums and gels, requiring pre-dissolving or solubilization design; crystallization causes non-uniform content, affecting batch stability and efficacy consistency; high-ethanol / high-oil solubilization limits sensory feel and dosage-form options; the active’s theoretical efficacy is hard to convert reliably into finished-product performance.
The Industry Recognized This Long Ago
As early as 2001, an international cosmetics group filed a patent around “solubilizing pentacyclic triterpenic acids” (US 2001/0029266 A1), improving dispersion through specific emulsifier systems. Review literature likewise notes that oleanolic acid’s low water solubility limits its bioavailability, with structural modification and delivery systems as the two solution paths.
Solving the formulation bottleneck matters more than discovering yet another benefit — this is exactly where OleaXin™ starts.
References: US 2001/0029266 A1; Wang W et al. Curr Top Med Chem. 2022;22(1). DOI:10.2174/1568026621666211105101231.
04 · THE SOLUTION
PuriActives® OleaXin™ — Rebuilding Oleanolic Acid as a Nanogel
OleaXin™ converts highly lipophilic oleanolic acid, through phospholipid association and nanostructured dispersion, into a Nanogel active format compatible with aqueous systems — without changing the molecule itself, only the way it exists in a formula.
| INCI NAMEOleanolic Acid 石竹素Phospholipids 磷脂 · Glycerin 甘油 · Water 水 | DESIGN LOGICOleanolic acid + phospholipids + glycerin + water→ Nanogel Delivery System |
| a. Nanostructured deliveryNanostructured presentation of a lipophilic active | b. Aqueous compatibilityAqueous-compatible format for modern chassis |
| c. Formulation-friendly dispersionImproved dispersion, fewer pre-dissolving steps | d. Skin & scalp versatilityOne active for both skin and scalp care |
齐肤因™ is the Chinese product name of PuriActives® OleaXin™. This material is for cosmetic ingredient technical exchange only and involves no pharmaceutical claims.
05 · DELIVERY ENGINEERING
From Crystalline Active to Nanogel: An Engineered Pathway

What It Means at the Formulation Level
· Improved aqueous dispersion · Lower crystallization risk · Simpler pre-dissolving · Broader dosage-form options · Better formula uniformity
Core conversion logic: Hard-to-Formulate Bioactive ——→ Ready-to-Use Advanced Active
Technical note: this page illustrates the delivery system design principle. OleaXin™’s specific particle size, encapsulation efficiency, and penetration data are subject to measured values in the PuriPharm TDS; without cited measured data, this material does not use statements such as “penetration increased by XX%.”
06 · BIOLOGICAL LANDSCAPE
One Active, Multiple Skin and Scalp Biology Pathways

The pentacyclic triterpene scaffold determines oleanolic acid’s potential to interact with multiple cellular signaling pathways. The following chapters unfold in the order of mechanism → data → biological significance → cosmetic value, each pathway annotated with traceable literature or patent evidence and its evidence level.
07 · SEBUM REGULATION
Oil Balance: Starting from Sebaceous Gland Biology

Sebum secretion is governed by androgen signaling: testosterone is converted by 5α-reductase into the more potent DHT, driving sebaceous gland hyperplasia and lipid synthesis. 5α-reductase is therefore a classic target for oil-control actives.

Human Efficacy Reference: An Oleanolic Acid-Containing Blend
28-day half-face controlled use test (3% blend, n≈20, oily-skin panel); multi-ingredient system, not attributable to oleanolic acid alone.
| -21.7%skin gloss (mean) | -16%pore surface area (mean) | -32%sebum flow (mean) |
Reading the Evidence
· Oleanolic acid’s 5α-reductase inhibition is direct in-vitro enzymatic evidence (patent assay data);· The human data come from a multi-ingredient blend containing oleanolic acid, indicating the mechanism’s market translation value;· Sebum management should also address inflammation and oxidative stress (next page).
Data sources: US 7,182,963 B2 (in-vitro 5α-reductase enzymatic assay); attached technical documentation (28-day human test of an oleanolic acid-containing blend).
08 · BLEMISH-PRONE SKIN
Blemish-Prone Skin Is Not a Single-Pathway Problem
Blemish formation involves the interplay of excess sebum, abnormal follicular duct keratinization, the microbial environment, and inflammatory responses. Oleanolic acid’s value lies in evidence covering several of these links — not merely “antibacterial anti-acne.”
| ① Sebum secretion5α-reductase / androgen-driven lipid synthesis | ② Follicular environmentDuct keratinization and sebum retention form the comedone microenvironment | ③ Microbial factorsCutibacterium acnes-related flora environment | ④ Inflammatory responseNF-κB-driven redness and discomfort |
Where Oleanolic Acid’s Evidence Sits in Each Link
■ Sebum link Concentration-dependent 5α-reductase inhibition (56.3% at 0.1%, in-vitro enzymatic assay)■ Microbial link Patent literature reports inhibitory activity against C. acnes and other skin-related flora■ Inflammation link Modulates NF-κB / STAT1 signaling in keratinocytes and animal models (detailed next page)■ Barrier link Promotes epidermal differentiation and barrier recovery, helping blemish-prone skin maintain a more stable state
Translated into Cosmetic Language
· Oily and blemish-prone skin care · Sebum balance management · Pore oil-environment management · Soothing discomfort of blemish-prone skinNo pharmaceutical claims such as “treating acne”; mechanistic evidence supports the product’s scientific narrative.
References: US 7,182,963 B2; Kang YM et al. Int J Mol Sci. 2021;22:12000; Lim SW et al. J Dermatol. 2007;34:625-634.
09 · INFLAMMATORY BALANCE
Stabilizing Stressed Skin from the Source of Inflammatory Signaling


Mechanistic Evidence: Cell and Animal Levels Corroborate Each Other
In vitro (HaCaT keratinocytes) Under TNF-α / IFN-γ stimulation, oleanolic acid blocked the activation of Akt, NF-κB, and STAT1, and suppressed Th2-type cytokine and chemokine expression.
In vivo (DNCB mouse model) Three weeks of topical dosing significantly relieved dermatitis-like lesions, reducing epidermal/dermal thickness, mast cell infiltration, and serum histamine levels.
Cosmetic value Helps soothe irritated skin · Maintains a healthy inflammatory balance · Improves skin comfort under stressful environments
Data source: Kang YM et al. Int J Mol Sci. 2021;22(21):12000. DOI:10.3390/ijms222112000 (animal and cell evidence, not human clinical conclusions).
10 · OXIDATIVE STRESS DEFENSE
Helping Skin Build Stronger Stress Defense
An Honest Scientific Positioning: It Is Not a Classic “Antioxidant”
DPPH radical-scavenging assays show oleanolic acid’s direct scavenging capacity is weak (only 9.2% at 100 µM, roughly equivalent to 4.45 µM Trolox). Its value lies in another path: pharmacological research links the oleanolic acid scaffold to the Keap1 / Nrf2 endogenous defense system and downstream antioxidant enzymes (HO-1, NQO-1), and it reduces oxidative stress markers in inflammation models.


Cell Compatibility: Evidence in Human Skin Fibroblasts
24-hour cytotoxicity assay: oleanolic acid (OA) showed no cytotoxicity up to 100 µM; its isomer ursolic acid (UA) had an IC₅₀ of 47.5 µM (MTT). OA is the gentler triterpene choice.
Cosmetic value Supports the cell’s endogenous defense against environmental stress · Helps maintain a more stable skin state
Data sources: Wójciak-Kosior M et al. Folia Histochem Cytobiol. 2011;49(4):664-669. DOI:10.5603/FHC.2011.0050; Wang W et al. Curr Top Med Chem. 2022;22(1).
11 · EPIDERMAL HOMEOSTASIS
Epidermal Homeostasis: Experimental Evidence for Barrier Resilience


Mechanistic Landing Point: PPAR-α and Epidermal Differentiation Markers
In HaCaT keratinocytes, oleanolic acid (10 µmol/L, 24 h) raised PPAR-α, involucrin, loricrin, and filaggrin protein expression to about 2× control; electron microscopy showed increased lamellar body secretion and more complete lipid bilayer formation.
Cosmetic value Supports epidermal homeostasis and barrier resilience · Helps maintain healthy skin barrier function · Completes the oily-skin care logic together with oil control and soothing
Data source: Lim SW et al. J Dermatol. 2007;34(8):625-634. DOI:10.1111/j.1346-8138.2007.00344.x (animal and cell evidence).
12 · MATRIX PROTECTION
Guarding the ECM: From Oxidative Stress to Collagen Degradation

▲ Oleanolic acid’s known evidence sits at upstream nodes: modulating oxidative stress and inflammatory signaling (NF-κB / MAPK family), influencing the matrix degradation cascade from its source.
ECM-Related Evidence Leads
■ Delivery + collagen patent An oleanolic acid liposome composition patent (CN 103221028 B) targets collagen production, showing that “delivery technology + ECM” is an industry-recognized R&D path■ Photoaging use patent A composition patent for pentacyclic triterpenic acids in preventing photoaging and sensitive skin (US 2001/0029266 A1)■ Mechanistic level MAPK / NF-κB modulation evidence (see the inflammation chapter) covers upstream MMP signaling
Evidence Boundary Statement
Current ECM-related evidence for oleanolic acid consists mainly of patents and mechanistic studies; human anti-wrinkle clinical data are still lacking. This material therefore avoids statements like “reduces wrinkles by XX%” and instead positions oleanolic acid as an upstream modulator of the oxidative stress – inflammation – matrix degradation cascade.
Cosmetic value Supports ECM homeostasis · Helps reduce stress-induced matrix degradation · Maintains a collagen-rich skin structure · Supports skin elasticity and firmness
References: CN 103221028 B; US 2001/0029266 A1; Kang YM et al. Int J Mol Sci. 2021;22:12000 (patent- and mechanism-level evidence).

PART II · SCALP SCIENCE
Skin biology doesn’t stop at the hairline.
From skin to scalp — shared sebum, inflammation, and oxidative stress biology.
The scalp is an extension of the skin: dense sebaceous glands, dense follicles, and androgen sensitivity. The mechanistic evidence for oleanolic acid in facial sebum management applies equally to the scalp scenario.
13 · SCALP & ANDROGEN BIOLOGY
Scalp Oil and Androgen Biology: Same Target, Second Scenario

Recalling the page-8 data: oleanolic acid concentration-dependently inhibits 5α-reductase in vitro (56.3% inhibition at 0.1%, US 7,182,963 B2) — a mechanism pointing to both facial sebum and scalp oil scenarios.
What Makes the Scalp Scenario Special
· High sebaceous gland density: oil oxidation products and flora metabolites together form an irritation source· Follicles are sensitive to androgen signaling; DHT-related follicular microenvironment stress is a focus of hair-care research· Scalp care is shifting from “hair-fiber cosmetic finish” to “scalp ecology management”
Compliant Cosmetic Language
· Helps maintain a healthy scalp oil environment · Supports scalp ecological balance · Helps maintain a healthy follicular microenvironment · Supports scalp and follicle vitalityNo “anti-hair-loss / hair-growth / hair-loss treatment” claims.
References: US 7,182,963 B2; WO 2017/021247 A1 (hair-care composition patent containing oleanolic acid blends).
14 · FOLLICULAR MICROENVIRONMENT
The Follicular Microenvironment: More Than Just “Oil Control”
A 6-month open human study (56 subjects with androgenetic alopecia and telogen effluvium) showed that a scalp lotion containing oleanolic acid, apigenin, biotinyl tripeptide-1, and other ingredients significantly increased total hair count and anagen hair count. Oleanolic acid plays the 5α-reductase-modulating role in the blend.
Dermatologist Assessment (D180, full sample)
| 35.7%hair felt denser and fuller | 37.5%overall hair appearance improved | 39.3%scalp coverage improved |


Reading the Evidence
· Human data from a multi-ingredient blend cannot be attributed to oleanolic acid alone;· Yet it is directionally consistent with the in-vitro 5α-reductase evidence, forming a “mechanism + clinical signal” combination;· No adverse events were reported throughout, with favorable usability ratings.
Cosmetic narrative: balanced scalp oil → a healthier follicular environment → support for hair vitality. Focus on “scalp care,” not “hair-loss treatment.”
Data source: Garre A et al. J Cosmo Trichol. 2018;4(1):1000132. DOI:10.4172/2471-9323.1000132 (multi-ingredient blend, 6-month open study).
15 · WHY NANOGEL MATTERS
Why Does Nanogel Matter So Much for Oleanolic Acid?
| Conventional Oleanolic Acid (Crystalline Raw Material) | PuriActives® OleaXin™ (Nanogel Active System) |
|---|---|
| Poor compatibility with aqueous systems | Aqueous-compatible Nanogel format |
| Hard to disperse; requires pre-dissolving / solubilization design | Improved dispersion; more direct dosing |
| Crystallization / precipitation risk | Nanostructured presentation lowers recrystallization tendency |
| Limited dosage-form and formulation freedom | Greater formulation flexibility (serum / gel / emulsion / scalp essence) |
| A conventional active format | A delivery-enabled active for modern formulations |
Each comparison dimension corresponds to verifiable technical basis: oleanolic acid’s lipophilicity and solubilization difficulty are documented in literature and patents (US 2001/0029266 A1; Wang et al. 2022); Nanogel-side statements describe delivery system design characteristics, with specific parameters subject to measured values in the PuriPharm TDS.
16 · FORMULATOR VALUE
What Does It Mean for Formulators?
- A more convenient way to use oleanolic acid No need to solve solubilization from scratch; the active is dosed directly in water-dispersible form
- Greater formulation freedom Less reliance on high-ethanol or high-oil solubilization
- Compatible with modern water-based serum systems Works in serums, gels, emulsions, and other mainstream formats
- Skin Care + Scalp Care dual scenarios One active covers both facial and scalp product lines
- Fewer complex pre-dissolving steps Shorter process chain and lower batch-to-batch content-variation risk
- An easy nano-technology product story The Nanogel delivery narrative combines scientific credibility with market recognition
- Supports lightweight dosage forms Matches the “fresh, non-greasy feel” brief of oily-skin care
Hard-to-Formulate Bioactive → Ready-to-Use Advanced Active
17 · APPLICATIONS — SKIN CARE
Skincare Applications: Every Direction Has a Biological Basis
| Sebum balance serum | 5α-reductase modulation acting on upstream sebum-signaling (in-vitro enzymatic evidence) |
| Blemish-care serum | Multi-link support across sebum + microbial environment + inflammatory signaling (in-vitro / animal evidence) |
| Lightweight oil-control moisturizer | Aqueous-compatible Nanogel format suits fresh, light-feel systems (delivery system design feature) |
| Soothing serum | NF-κB / STAT1 inflammatory-signal modulation improves comfort under stress (animal + cell evidence) |
| Antioxidant defense serum | Supports endogenous defense pathways rather than relying on direct radical scavenging (mechanism-level evidence) |
| Anti-aging direction serum | Upstream modulation of the oxidative stress – inflammation – matrix degradation cascade (patent and mechanistic evidence) |
| Urban stress protection | Dual oxidative + inflammatory stress management for UV / pollution scenarios (mechanism-level evidence) |
Application directions are development suggestions; specific efficacy claims must be based on finished-formula efficacy evaluations; evidence levels are annotated in each row.
18 · APPLICATIONS — SCALP CARE
Scalp-Care Applications: A Scalp-First Formulation Mindset
From “smoothing the hair fiber” to managing scalp ecology — this is the upgrade direction the scalp-care category is undergoing.
| Scalp balance serum | Scalp sebum modulation and oil-environment management (supported by in-vitro 5α-reductase evidence) |
| Oil-control scalp serum | A fresh, water-based-compatible formula for oily scalps |
| Leave-on scalp lotion | A leave-on format covering follicular microenvironment management |
| Soothing scalp care | Inflammatory-signal modulation to help relieve scalp discomfort (animal + cell evidence) |
| Hair vitality essence | Follicular microenvironment + oxidative stress management supporting a healthy hair-growth environment (multi-ingredient clinical signal) |
| Anti-grease scalp care | Daily management of scalp oil oxidation and the flora environment |
Compliance note: scalp applications focus on “scalp care” and the “hair vitality environment”; no anti-hair-loss, hair-growth, or hair-loss-treatment claims; multi-ingredient human study data serve only as directional mechanistic reference.
19 · CONCEPT SHOWCASE
Product Concept Examples
OleaXin™ Sebum Reset Serum
Sebum regulation + inflammatory balance + oxidative defense — a daily management serum for oily skin
OleaXin™ Clear Balance Essence
Environment management for blemish-prone skin: sebum balance + microbial environment + soothing
OleaXin™ Matrix Defense Serum
Upstream defense against oxidative stress and the matrix degradation cascade — anti-aging direction
OleaXin™ Scalp Balance Serum
A scalp-balancing serum covering scalp sebum + soothing + follicular microenvironment
OleaXin™ Follicular Vitality Essence
A leave-on scalp essence for oxidative stress + follicular environment + scalp vitality
Concept Design Principles
· Each concept maps to a defined combination of biological targets, not a pile-up of claims;· Concepts are development-direction examples only and contain no experimentally unverified formula ratios;· For use levels, compatibility, and stability data, refer to the PuriPharm TDS and formulation guide;· Finished-product efficacy claims are subject to the final product’s efficacy evaluation.
20 · VALUE SUMMARY
OleaXin™ Core Value: Three Pillars
| PILLAR IMultifunctional Biology | PILLAR IIAdvanced Delivery | PILLAR IIIFormulation Value |
|---|---|---|
| Sebum regulation · inflammatory balanceOxidative stress defense · ECM protectionEpidermal homeostasis · scalp homeostasisA multi-target evidence chain, from in-vitro enzymology to human study signals | Phospholipid Nanogel delivery systemNanostructured presentationAqueous-system compatibilityChanging how the active exists in a formula, not the molecule itself | Flexible formats · easy dosingSkin & scalp dual-scenario coverageA nano-technology product narrativeFrom hard-to-formulate bioactive to ready-to-use advanced active |
Bringing the scientific potential of oleanolic acid into modern formulations.UNLOCKING THE COSMETIC POTENTIAL OF OLEANOLIC ACID
21 · SELECTED REFERENCES
Key References and Patents
Peer-Reviewed Papers
[1] Kang YM, Kim HM, Lee M, An HJ. Oleanolic Acid Alleviates Atopic Dermatitis-like Responses In Vivo and In Vitro. Int J Mol Sci. 2021;22(21):12000. DOI:10.3390/ijms222112000[2] Lim SW, Hong SP, Jeong SW, et al. Simultaneous effect of ursolic acid and oleanolic acid on epidermal permeability barrier function and epidermal keratinocyte differentiation via PPAR-α. J Dermatol. 2007;34(8):625-634. DOI:10.1111/j.1346-8138.2007.00344.x[3] Wójciak-Kosior M, Paduch R, Matysik-Woźniak A, et al. The effect of ursolic and oleanolic acids on human skin fibroblast cells. Folia Histochem Cytobiol. 2011;49(4):664-669. DOI:10.5603/FHC.2011.0050[4] Garre A, Piquero J, Trullas C, Martinez G. Efficacy and Safety of a New Topical Hair Loss-Lotion Containing Oleanolic Acid, Apigenin, Biotinyl Tripeptide-1, Diaminopyrimidine Oxide, Adenosine, Biotin and Ginkgo biloba. J Cosmo Trichol. 2018;4(1):1000132. DOI:10.4172/2471-9323.1000132 (multi-ingredient blend)[5] Ayeleso TB, Matumba MG, Mukwevho E. Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases. Molecules. 2017;22(11):1915. DOI:10.3390/molecules22111915[6] Wang W, Li Y, Li Y, et al. Oleanolic Acid: Structural Modification and Biological Activities. Curr Top Med Chem. 2022;22(1). DOI:10.2174/1568026621666211105101231
Patents and Technical Documentation
[7] US 7,182,963 B2. Cosmetic and dermopharmaceutical compositions for skin prone to acne (contains in-vitro 5α-reductase enzymatic data for oleanolic acid; family: US 2006/0239957 A1)[8] US 2001/0029266 A1. Composition containing a pentacyclic triterpenic acid (solubilization of pentacyclic triterpenic acids)[9] WO 2017/021247 A1. Anti-hair loss lotion (hair-care composition containing oleanolic acid blends)[10] CN 103221028 B. Oleanolic acid liposome composition (collagen direction)[11] CN 103648502 B. Anti-inflammatory use of oleanolic acid acetate[12] Attached technical documentation: 28-day human efficacy test of an oleanolic acid-containing blend (gloss / pores / sebum flow, n≈20)
Disclaimer
This material is prepared by PuriPharm Co., Ltd. for cosmetic ingredient technical exchange only and constitutes no pharmaceutical or medical claims. In-vitro / animal study data do not represent finished-product human efficacy; third-party literature and patent data are cited as technical background only. Customers should independently verify the suitability and regulatory compliance of their finished formulations. PuriActives® and OleaXin™ are trademarks of PuriPharm Co., Ltd.
PuriPharm Co., Ltd. · www.puriactives.com · service@puripharm.com













































































